Colossal

Colossal Partners with Mauritian Wildlife Foundation To ‘Rewild’ the Dodo, as Another Bird Gets a ‘Genetic Rescue’

by | Nov 27, 2023
“The dodo is the symbol of man-caused extinction,” Dallas-based Colossal Co-Founder and CEO Ben Lamm said last January. “It’s only fitting that Colossal works to reverse that.” The newly announced partnership with the MWF could help advance Colossal's efforts by restoring the dodo's natural habitat.
MORE
Here Be Dragons: Colossal Partners with Zoos Victoria To Save Reptile Once Thought Extinct
by | Oct 25, 2023
OK, it may not be as big—or as fire-breathing—as the dragons that swooped over Westeros on "Game of Thrones." But Australia's Victorian Grassland Earless Dragon is every bit as magical for simply hanging in there, decades after many thought it was extinct. Now Texas-based Colossal Biosciences is partnering to help preserve it—and sequence its genome.
MORE
Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE
16 Biotech Companies in Dallas-Fort Worth ‘Putting the Tech in Bio’ to Drive Breakthroughs

Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....

MORE

Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO

by | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas. Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE
Mammoth Interest: The CIA Invests in Dallas-Based Colossal Biosciences
by | Oct 11, 2022
The Central Intelligence Agency has invested in Colossal through its nonprofit VC investment arm, In-Q-Tel, reports The Intercept. Named in honor of Q—the tech genius from the James Bond novels and movies—the VC firm was founded in 1999 to keep U.S. intelligence agencies on the cutting edge of "innovative and impactful technologies coming out of Silicon Valley and beyond." So why Colossal? "Strategically, it’s less about the mammoths and more about the capability," In-Q-Tel says.
MORE
Dr. Venu Varanasi, pictured in his lab,an associate professor and lab director at UT Arlington, won the pitch competition.
UT Arlington Researcher Takes Home Pitch Competition Prize for Bone Regeneration Work
by | Sep 26, 2022
After a rigorous process, the top six applications to the Tech Transfer Office Showcase at BioNTX's iC3 life science summit were invited to pitch live at BioNTX's life science summit. Industry experts rated, graded, and discussed the technologies prior to the pitches "We want to cultivate technologies that are coming out of the university ecosystem here—and we want them to stay here," said Chad Ronholdt, managing director at NVB Ventures.
MORE
Mammoth Project: Dallas’ Colossal Raises $60M to Advance Genetic Engineering and ‘De-Extinction’ Technologies
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid. With a total raise of $75 million to date, the startup aims to have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE